CACharles Martins Aguilar

Charles Martins Aguilar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Charles Martins Aguilar has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Propolis extract: antioxidant effects and potential implications for human health in sleep

    by Tamirys Caroline Silva Souza, Suelaine Barbosa de Oliveira, Laudelina Ferreira de Andrade, Patrícia Soares Rocha, Karla Sabrina Magalhães Andrade Padilha, João Gabriel Silva Souza, Charles Martins Aguilar, Caroline Honaiser Lescano, Dario Alves Oliveira, Igor Viana Brandi, et al.

    Propolis is a natural product produced by bees from plant exudates found around hives, serving as a protective barrier against microorganisms and environmental factors. Its therapeutic use dates back to ancient civilizations, and in recent decades, propolis extract has gained increasing scientific attention due to its chemical diversity and wide range of biological effects, particularly as a remedy for various diseases, which highlight its therapeutic potential and applicability in different health-related areas. Despite the growing scientific interest in the bioactive properties of propolis extract, most investigations have focused on its antioxidant, anti-inflammatory, and antimicrobial effects, with a scarcity of systematized evidence regarding its direct influence on sleep quality in adults. Considering the clinical and social relevance of sleep disorders—associated with increased oxidative stress and a higher risk of metabolic, cardiovascular, and neurodegenerative diseases—a critical and comprehensive analysis of the literature is necessary. This study aims to gather and evaluate the available evidence on the combined effects of a healthy diet and propolis extract on sleep quality, offering an innovative and complementary perspective compared with previously published works.

  • Open Access

    Microencapsulated Syzygium aromaticum essential oil enhances β-lactam efficacy against multidrug-resistant Staphylococcus aureus

    by Ellem Cristina Gomes Damascena, Eliane Macedo Sobrinho Santos, Carolina Magalhães Caires Carvalho, Charles Martins Aguilar, Cintya Neves de Souza, Francine Souza Alves da Fonseca, Ivan Pires De Oliveira, Adriana Fróes Do Nascimento Souto, Hércules Otacílio Santos, Anna Christina de Almeida

    Background and Aim: Antimicrobial resistance (AMR) is a major One Health concern, especially in dairy production systems where multidrug-resistant (MDR) Staphylococcus aureus limits mastitis control. Essential oils (EOs), such as Syzygium aromaticum EO, possess strong antimicrobial properties, but their volatility restricts stability. Microencapsulation enhances EO stability and functional performance. This study aimed to evaluate the antimicrobial effect of microencapsulated S. aromaticum EO (OESAM) combined with β-lactam antibiotics against MDR S. aureus. Additionally, bioinformatic analysis was used to explore the potential role of whey protein isolate (WPI) used in the microcapsule wall material in modulating antimicrobial action. Materials and Methods: OESAM was prepared via complex coacervation using WPI and gum arabic as wall materials. Ten MDR S. aureus isolates from bovine mastitis were tested for minimum inhibitory concentrations (MICs) of OESAM, oxacillin, and meropenem using broth microdilution. Synergy was evaluated using the Checkerboard method and interpreted through the fractional inhibitory concentration index (FICI). A protein–protein interaction network was generated in STRING database to investigate molecular pathways potentially affected by amino acids in WPI. Results: Microencapsulation produced stable microcapsules with a yield of 39.11%. The addition of OESAM significantly reduced the MICs of oxacillin and meropenem (p < 0.05), resulting in antimicrobial dose reductions of up to 2.7-fold. Synergistic and additive effects predominated among the isolates. These outcomes were further supported by their FICI values, which confirmed potentiation between OESAM and β-lactams. Bioinformatic analysis identified three major functional clusters: tryptophan biosynthesis, siderophore biosynthesis, and phosphorelay signal transduction, suggesting that amino acids present in WPI may interfere with metabolic and regulatory pathways of S. aureus, enhancing antimicrobial effectiveness. Conclusion: OESAM substantially enhances β-lactam efficacy against MDR S. aureus, offering a promising strategy for reducing antimicrobial doses and combating resistance in veterinary practice. Microencapsulation improves EO stability and enables controlled-release, thereby enhancing antimicrobial activity. Further in vivo validation, toxicity assessment, and formulation development are recommended to facilitate practical applications in mastitis control and broader AMR mitigation. Keywords: antimicrobial resistance, Staphylococcus aureus, fractional inhibitory concentration index, mastitis, microencapsulation, One Health, Synergy, Syzygium aromaticum, whey protein isolate.

  • Ovalbumin-Urea Interactions Study at Distinct pH Range via Ultrasonic Investigation and Molecular Dynamics Simulations Dhivya Boomibalan1, Agalya Palanisamy2, Sasikumar Ponnusamy3, Kaique Mendes de Souza 4, Ruth Maria Rocha Ribeiro4, Alexandre Borges4, Charles Martins Aguilar4, Caroline Honaiser Lescano4,5, Dario Alves de Oliveira6, Ivan Pires de Oliveira4,* Velusamy Veerappan1*

    by Divya Boomibalan, Agalya Palanisamy, P. Sasikumar, Kaique Mendes de Souze, Ruth Maria Rocha Ribeiro, Alexandre Borges, Charles Martins Aguilar, Caroline Honaiser Lescano, Dario Alves de Oliveira, Ivan Pires de Oliveira, et al.

    This article discusses the Ovalbumin (OVA)-urea interactions combined with distinct pH range by molecular interaction studies. This was studied experimentally by means of density, ultrasonic velocity, viscosity and surface tension...

  • Open Access

    Molecular analysis of Kefiran exopolysaccharide: Interactions with vitamins, amino acids, monosaccharides, lipids, and Toll-like receptor 4

    by Laudelina Ferreira de Andrade, Rebeca Santana da Costa, Melissa Biazzi Fila, Daniela Cácia dos Santos, Tamirys Caroline Silva Souza, Charles Martins Aguilar, Sérgio Henrique Sousa Santos, Igor Viana Brandi, Caroline Honaiser Lescano, Ivan Pires de Oliveira

    Kefir grains are composed of a consortium of microorganisms, which are enveloped in a matrix of exopolysaccharides called kefiran, with an almost equal proportion of D-glucose and D-galactose, produced by lactic acid bacteria of the genus Lactobacillus. Associated with a diversity of proteins and lipids, kefiran supports the symbiotic cellular structure and protects it against external influences, such as nutrient deficiencies, dehydration, bacteriophages, toxicity, and osmosis. Kefiran has attracted the attention of the scientific community due to its functional properties, and its role in modulating the immune system is the most studied and has potential for exploration. However, the biopolymer has a complex molecular structure and its physical and chemical properties still require investigation. The present study addresses the interaction between the kefiran tetramer and various compounds: trivalerate triacylglycerol; monosaccharide — D-glucose; fat-soluble vitamins such as vitamin A — retinol and vitamin D — cholecalciferol; water-soluble vitamins such as vitamin B2 — riboflavin and vitamin C — ascorbic acid; and amino acids such as positive side chain histidine, negative aspartate, polar asparagine, and hydrophobic isoleucine. From its molecular properties and experimental results from the literature, we discuss the role of kefiran in acting similarly to the carbohydrate portion of lipopolysaccharides in the Toll-like receptor and myeloid differentiation factor 2 system, activating the immune system.

  • Open Access

    Atividade antibacteriana e antibiofilme de óleo essencial de Syzygium aromaticum microencapsulado e não microencapsulado

    by Daniele Pereira de Souza Borborema, Cintya Neves de Souza, Carolina Magalhães Caires Carvalho, Charles Martins Aguilar, Fernando Eustáquio de Matos Júnior, Ulisses Alves Pereira, Ester Dias Xavier, Alessandra Rejane Ericsson de Oliveira Xavier, Janaína Teles de Faria, Anna Christina de Almeida

    The aim of this work was to evaluate the antibacterial and antibiofilm activity of microencapsulated and non-microencapsulated clove (Syzygium aromaticum) essential oil on multidrug-resistant Staphylococcus aureus strains. Antibacterial activity was performed by disk diffusion and broth microdilution techniques to determine the Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) of the essential oil. For the antibiofilm activity, strains of S. aureus that were sensitive to the action of the essential oil were used. Five isolates were sensitive to the action of the essential oil by the disk diffusion test whose MIC was 10 μL.mL-1 and the CBM was 20 μL.mL-1. Of these five, four were able to form biofilms with adhesion greater than 107 CFU.cm-2. The microencapsulated oil showed a better antibiofilm effect with a reduction of about 2 log CFU.cm-2 in the multiresistant S. aureus analyzed, and the non-microencapsulated oil reduced approximately 1.1 log CFU.cm-2 showing the high efficiency of the oil with microencapsulation. The use of microencapsulated Syzygium aromaticum essential oil could serve as a promising alternative in the control of multiresistant and biofilm forming bacteria on stainless steel surfaces, presenting some advantages compared to the one used in its original form, mainly with regard to transport, content preservation, handling and use in food matrices.


  • Analysis of Essential Oil from Brazilian Mentha x piperita L. Commercial Samples

    by Ulisses Alves Pereira, Charles Martins Aguilar, Maria Cecília Fernandes Dias, Gustavo Luis D’grande, Patrícia Fontes Pinheiro, Vanessa Moreira Osório


  • Open Access

    Protein-coding gene interaction network prediction of bioactive plant compound action against SARS-CoV-2: a novel hypothesis using bioinformatics analysis

    by Eliane M. Santos Sobrinho, Hércules O. Santos, Ernane R. Martins, Francine Souza Alves DA Fonseca, Lucyana C. Farias, Charles M. Aguilar, Ulisses A. Pereira, Nilson Nicolau Junior, Matheus S. Gomes, Cintya N. DE Souza, et al.

    This study aimed to verify the action of bioactive compounds from Brazilian plants on the leader genes involved in the SARS-CoV-2 pathway. The main human genes involved were identified in GeneCards and UNIPROT platforms, and an interaction network between leader genes was established in the STRING database. To design chemo-biology interactome networks and elucidate the interplay between genes related to the disease and bioactive plant compounds, the metasearch engine STITCH 3.1 was used. The analysis revealed that SMAD3 and CASP3 genes are leader genes, suggesting that the mechanism of action of the virus on host cells is associated with the molecular effects of these genes. Furthermore, the bioactive plant compounds, such as ascorbate, benzoquinone, ellagic acid, and resveratrol was identified as a promising adjuvant for the treatment inhibiting CASP3-mediated apoptosis. Bioactive plant compounds were verified as the main pathways enriched with KEGG and related to viral infection, assessments/immune/infections, and cell proliferation, which are potentially used for respiratory viral infections. The best-ranked molecule docked in the CASP3 binding site was rutin, while the SMAD3 binding site was resveratrol. In conclusion, this work identified several bioactive compounds from Brazilian plants showing potential antiviral functions that can directly or indirectly inhibit the new coronavirus.